Overview

Sugammadex Compared With Neostigmin/Atropin for Neuromuscular Block Reversal in Patients With Obstructive Sleep Apnea

Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
Incomplete recovery of neuromuscular function after surgery can lead to respiratory complications. Patients with obstructive sleep apnea (OSA) are prone to respiratory complications after surgery. Neostigmin and sugammadex are used for neuromuscular reversal. The aim of this study was to compare sugammadex and neostigmin regarding efficacy, incidence of respiratory complications and cost in patients undergoing surgery for OSA
Phase:
Phase 4
Details
Lead Sponsor:
Diskapi Teaching and Research Hospital
Treatments:
Neostigmine